Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas

Dermatology

Volumn 221, Issue 4, 2010, Pages 356-364

  Alijotas Reig, Jaume ^a,c,d   Miró Mur, Francesc ^a   Planells Romeu, Irene ^a,c   Garcia Aranda, Natalia ^a   Garcia Gimenez, Victor ^a,b   Vilardell Tarrés, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Europa Medical Center   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Josep MA de Segarra   (Spain)

Author keywords

Bacterial infection; Chemotaxis; Filler injections; Granulomas; Treatment

Indexed keywords

ACRYLIC ACID DERIVATIVE; BIOMATERIAL; COLLAGEN; FILLER; HYALURONIC ACID; HYALURONIDASE; HYDROXYAPATITE; METHACRYLIC ACID; POLYACRYLAMIDE; POLYALKYLIMIDE; POLYLACTIC ACID; SILICONE OIL; UNCLASSIFIED DRUG;

AGAR MEDIUM; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLAGELLUM; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CHEMOTAXIS; CONTROLLED STUDY; ESCHERICHIA COLI; EXPERIMENTAL STUDY; GRANULOMA; HUMAN; INOCULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ACRYLIC RESINS; BIOCOMPATIBLE MATERIALS; CHEMOTAXIS; COSMETIC TECHNIQUES; DURAPATITE; ESCHERICHIA COLI; GRANULOMA, FOREIGN-BODY; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS;

EID: 78650977358     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321329     Document Type: Article

References (39)

1. De Boulle K: Management of complications after implantation of fillers. J Cosmet Dermatol 2004; 3: 2-15.
2. Ellis DA, Makdessian AS, Brown DJ: Survey of future injectables. Facial Plast Surg Clin North Am 2001; 9: 405-411.
3. Castillo-Vico MT, Checa-Vizcaino MA, Pava- Panades A: Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 207; 18: 95-97.
4. Bernauer W, Thiel MA, Kurrer M, et al: Corneal calcification following intensified treatment with sodium hyaluronate artificial tears. Br J Ophthalmol 2006; 90: 385-388.
5. Frank PJ: Cosmetic symposium: Restylane. The Dermatologic Society of Greater New York. Available at: http://www.dersociety.org/default.asp?id= 3&aui=sa&aid=35 (accessed February 2, 2005).
6. Engelman DE, Bradley B, Glodberg DJ: Dermal fillers: complications and informed consent. J Cosmet Laser Ther 2005; 7: 29-32.
7. Duffy DM: Complications of fillers: overview. Dermatol Surg 2005; 31: 1626-1633.
8. Bergeret-Galley C: Comparison of resorbable soft-tissue fillers. Aesthetic Surg J 2004; 24: 33-46.
9. Cohen JL: Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34(suppl):S92-S99.
10. Cristal RG: Sarcoidosis; in: Kasper DL, et al (eds). Harrison's Principles of Internal Medicine, ed 16. New York, McGraw-Hill, 2005, pp 2017-2023.
11. James DG: Sarcoidosis 2001. Postgrad Med J 2001; 77: 177-180.
12. Alijotas-Reig J, Garcia-Gimenez V: Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol 2008; 22: 150-161.
13. Christensen L: Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007; 33(suppl 2):S168-S175.
14. Christensen L, Breiting V, Janssen M, et al: Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29: 34-48.
15. Blank M, Krause I, Fridkin M, et al: Bacterial induction of autoantibodies to-2 - glycoprotein- I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002; 109: 797-804.
16. Getts MT, Miller SD: 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: triggering of autoimmune diseases by infections. Clin Exp mmunol 2010; 160: 15-21.
17. Albert LJ, Inman RD: Molecular mimicry and autoimmunity. N Engl J Med 1999; 341: 2068-2074.
18. Alijotas-Reig J, Garcia-Gimenez V, Miró- Mur F, Vilardell-Tarrés M: Delayed immune- mediated adverse effects related to polyalkylimide dermal fillers: clinical findings and follow-up. Arch Dermatol 2008; 144: 637-642.
19. Alijotas-Reig J: Recurrent urticarial vasculitis related to nonanimal hyaluronic acid skin filler injection. Dermatol Surg 2009; 35: 395-398.
20. Alijotas-Reig J, Garcia-Gimenez V, Miró- Mur F, Vilardell-Tarrés M: Delayed immune- mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up. Dermatol Surg 2009; 35: 360-366.
21. Miró-Mur F, Hindié M, Kandhaya-Pillai R, et al: Medical-grade silicone induces release of proinflammatory cytokines in peripheral blood mononuclear cells without activating T cells. J Biomed Res B Appl Biomater 2009; 90: 510-520.
22. Alijotas-Reig J, Miró-Mur F, Kandhaya-Pillai R, Schwartz S Jr: Bioengineered hyaluronic acid elicited a nonantigenic T-cell activation: implications from cosmetic medicine and surgery to nanomedicne. J Biomed Mater Res A 2010; 95: 180-190.
23. Le Minor L: Entérobacteries, éd 3. Saint- Mandé, Editions de la Tourelle, 1969.
24. Murray PR, Barm EJ, Jorgensen JH (eds): Manual of Clinical Microbiology, ed 9. Washington, ASM Press, 2007.
25. Christen U, von Herrath G: Infections and autoimmunity. Good or bad? J Immunol 2005; 174: 7481-7486.
26. Serrano C, Serrano S: Infección demorada tras el uso de Bio-Alcamid. Actas Dermosifiliogr 2006; 97: 460-462.
27. Goldan O, Georgiou I, Farber N, et al: Lateonset facial abscess formation after cosmetic soft tissue augmentation with Bio-Alcamid. Aesthetic Surg J 2007; 27: 416-418.
28. Goldan O, Georgiou I, Grabov-Nardini G, et al: Early and late complications after a nonabsorbable hydrogel polymer injection: a series of 14 patients and novel management. Dermatol Surg 2007; 33:S199-S206.
29. Jones DH, Carruthers A, Fitzgerald R, et al: Late-appearing abscesses after injections of nonabsorbable hydrogel polymer for HIVassociated facial lipoatrophy. Dermatol Surg 2007; 33:S193-S198.
30. Serrano-Grau P, Mascaró-Galy JM, Tranzo P, et al: Productos de relleno inyectables en dermocosmética. Tipos y efectos secundarios. Med Cutan Iber Lat Am 2007; 35: 209-218.
31. Pittet B, Montandon D, Pittet D: Infection in breast implants. Lancet Infect Dis 2005; 5: 94-106.
32. Brand KG: Infection of mammary prostheses: a survey and the question of prevention. Ann Plast Surg 1993; 30: 289-295.
33. Christensen LH, Breiting VB, Vuust J, et al: Adverse reactions following injections with permanent facial filler, polycrylamide hydrogel (Aquamid): causes and treatment. Eur J Plast Surg 2006; 28: 464-471.
34. Webster GF, Toso SM, Hegemann L: Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch Dermatol 1994; 130: 748-752.
35. Chrastil-LaTowsky B, Wesley NO, Mac- Gregor JL, et al: Delayed inflammatory reaction to Bio-Alcamid polyacrylamide gel used for soft tissue augmentations. Arch Dermatol 2009; 145: 1309-1312.
36. Arbuckle MR, McClain MT, Rubertone MV, et al: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
37. Wucherpfennig KW: Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001; 108: 1097-1104.
38. Rsachi E, Borghi MO, Grossi C, et al: Tolllike receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus 2008; 17: 937-942.
39. Chen K, Huang J, Gong W, et al: Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007; 7: 1271-1285.